First Midwest Bank Trust Division’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$401K Sell
1,557
-53
-3% -$14.5K 0.05% 290
2021
Q3
$440K Sell
1,610
-1,695
-51% -$539K 0.06% 270
2021
Q2
$740K Buy
3,305
+116
+4% +$21.9K 0.1% 212
2021
Q1
$348K Buy
3,189
+715
+29% +$75.9K 0.05% 303
2020
Q4
$202K Buy
+2,474
New +$243K 0.03% 346

Other funds holding BNTX

First Midwest Bank Trust Division's BNTX Position: Q4 2021 in Review

First Midwest Bank Trust Division reduced its BioNTech (BNTX) stake by 3.3% in Q4 2021, selling an estimated $14.5K and leaving 1,557 shares worth $401K. The position accounts for 0.05% of the portfolio, ranked #290.

First Midwest Bank Trust Division first reported a position in BNTX in Q4 2020 and has held it in 5 quarters since. The position peaked at $740K in Q2 2021. 354 funds tracked by Wall St. Rank hold BNTX as of Q4 2021.

  • First Midwest Bank Trust Division held 1,557 shares of BioNTech worth $401K as of Q4 2021.
  • First Midwest Bank Trust Division sold 53 BioNTech shares in Q4 2021, an estimated $14.5K.
  • BioNTech made up 0.05% of First Midwest Bank Trust Division's portfolio in Q4 2021, its #290 holding.
  • First Midwest Bank Trust Division first reported a position in BioNTech in Q4 2020 and has held it in 5 quarters since.
  • First Midwest Bank Trust Division's BioNTech position peaked at $740K in Q2 2021.
  • 354 funds tracked by Wall St. Rank held BioNTech as of Q4 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2021, filed 18 Jan 2022.